Annual Drug Patent Expirations for EDURANT Edurant is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Janssen Prods drug EDURANT appeared first o…
New patent expiration for Janssen Prods drug EDURANT Read Post »
Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are nine…
The post New patent expiration for Gilead Sciences drug COMPLERA appeared firs…
New patent expiration for Gilead Sciences drug COMPLERA Read Post »
Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent expiration for Viiv Hlthcare drug JULUCA appeared first on Dr…
New patent expiration for Viiv Hlthcare drug JULUCA Read Post »
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…
The post New patent expiration for Celgene drug REVLIMID appeared fi…
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent expiration for Astrazeneca Ab drug BYDUREON BCIS…
New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent expiration for Astrazeneca Ab drug BYDUREON BCIS…
New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON ap…
New patent expiration for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON ap…
New patent expiration for Astrazeneca Ab drug BYDUREON Read Post »
TARGINIQ (naloxone hydrochloride; oxycodone hydrochloride) Purdue pharma lp Patent: 8,846,090 Expiration: Apr 4, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Patent E…
Drug Patent Expirations for the Week of April 2, 2023 Read Post »
Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are fifteen patents protecting this drug. Drug patent…
The post New patent expiration for Purdue Pharma drug TARGINIQ appeared…
New patent expiration for Purdue Pharma drug TARGINIQ Read Post »